Cargando…

Commentary: pT3N2 non–small cell lung cancer: A heterogenous disease treated with homogenous therapy

Detalles Bibliográficos
Autores principales: Brandt, Whitney S., Meyers, Bryan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390274/
https://www.ncbi.nlm.nih.gov/pubmed/36004216
http://dx.doi.org/10.1016/j.xjon.2022.04.007
_version_ 1784770616982765568
author Brandt, Whitney S.
Meyers, Bryan F.
author_facet Brandt, Whitney S.
Meyers, Bryan F.
author_sort Brandt, Whitney S.
collection PubMed
description
format Online
Article
Text
id pubmed-9390274
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93902742022-08-23 Commentary: pT3N2 non–small cell lung cancer: A heterogenous disease treated with homogenous therapy Brandt, Whitney S. Meyers, Bryan F. JTCVS Open Commentary Elsevier 2022-04-15 /pmc/articles/PMC9390274/ /pubmed/36004216 http://dx.doi.org/10.1016/j.xjon.2022.04.007 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Brandt, Whitney S.
Meyers, Bryan F.
Commentary: pT3N2 non–small cell lung cancer: A heterogenous disease treated with homogenous therapy
title Commentary: pT3N2 non–small cell lung cancer: A heterogenous disease treated with homogenous therapy
title_full Commentary: pT3N2 non–small cell lung cancer: A heterogenous disease treated with homogenous therapy
title_fullStr Commentary: pT3N2 non–small cell lung cancer: A heterogenous disease treated with homogenous therapy
title_full_unstemmed Commentary: pT3N2 non–small cell lung cancer: A heterogenous disease treated with homogenous therapy
title_short Commentary: pT3N2 non–small cell lung cancer: A heterogenous disease treated with homogenous therapy
title_sort commentary: pt3n2 non–small cell lung cancer: a heterogenous disease treated with homogenous therapy
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390274/
https://www.ncbi.nlm.nih.gov/pubmed/36004216
http://dx.doi.org/10.1016/j.xjon.2022.04.007
work_keys_str_mv AT brandtwhitneys commentarypt3n2nonsmallcelllungcanceraheterogenousdiseasetreatedwithhomogenoustherapy
AT meyersbryanf commentarypt3n2nonsmallcelllungcanceraheterogenousdiseasetreatedwithhomogenoustherapy